SCHEMBL379946

SCHEMBL379946

C1=CCC2(C1)CCCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11775307 1.00
SCHEMBL11773518 1.00
Hydrochloric Acid SCHEMBL2311189 0.97
SCHEMBL3841158 0.96
SCHEMBL6364804 0.89
SCHEMBL314249 0.82
SCHEMBL11775152 0.82
SCHEMBL11770155 0.82
SCHEMBL11775030 0.82
SCHEMBL11775035 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1948167-A1 COMPOSITIONS OF PHOSPHODIESTERASE TYPE IV INHIBITORS RANBAXY LABORATORIES, LTD. (IN) 2008-07-30 EP claimed
WO-2007045980-A1 COMPOSITIONS OF PHOSPHODIESTERASE TYPE IV INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2007-04-26 WO claimed
US-20260116922-A1 HIGHLY STABLE OXYTOCIN DERIVATIVES UNIVERSITAET WIEN (AT) 2026-04-30 US disclosed
WO-2025093628-A1 ANTIGENIC SYNTHETIC PROTEINS CONTAINING A TETRAZINE-AMINO ACID VALANX BIOTECH GMBH (AT) 2025-05-08 WO disclosed
EP-4453003-A1 HIGHLY STABLE OXYTOCIN DERIVATIVES Universität Wien (AT) 2024-10-30 EP disclosed
EP-4342951-A1 IMIDAZO[1,2-A]PYRIDINIUM DERIVATIVES Universität Wien (AT) 2024-03-27 EP disclosed
WO-2024013150-A1 METHOD AND MEANS FOR SYNTHESIS OF C-NUCLEOSIDES OR C- NUCLEOTIDES TECHNISCHE UNIVERSITÄT GRAZ (AT) 2024-01-18 WO disclosed
EP-4306646-A1 METHOD AND MEANS FOR SYNTHESIS OF C-NUCLEOSIDES OR C-NUCLEOTIDES Technische Universität Graz (AT) 2024-01-17 EP disclosed
WO-2023118303-A1 HIGHLY STABLE OXYTOCIN DERIVATIVES UNIVERSITAET WIEN (AT) 2023-06-29 WO disclosed
US-20220356148-A1 ANTIVIRAL COMPOUNDS HAPLOGEN GMBH (AT) 2022-11-10 US disclosed
WO-2022200505-A1 IMIDAZO-, OXAZO-, THIAZO- PYRIDINIUM COMPOUNDS AS FLUORESCENT PROBES UNIVERSITAET WIEN (AT) 2022-09-29 WO disclosed
EP-2041116-A1 PHENYL SUBSTITUTED HETEROARYL-DERIVATIVES AND USE THEREOF AS ANTI-TUMOR AGENTS Boehringer Ingelheim International GmbH (DE) 2009-04-01 EP disclosed
WO-2009003998-A2 ANTIPROLIFERATIVE COMPOUNDS BASED ON 5-MEMBERED HETEROCYCLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-08 WO disclosed
WO-2009003999-A2 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-08 WO disclosed
WO-2008152013-A1 INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-12-18 WO disclosed
WO-2008152014-A2 3-HETROCYCLYLIDENE-INDOLINONE DERIVATIVES AS INHIBITORS OF SPECIFIC CELL CYCLE KINASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-12-18 WO disclosed
WO-2008107444-A1 9H- PURINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-09-12 WO disclosed
US-20080182837-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-07-31 US disclosed
WO-2008003770-A1 PHENYL SUBSTITUTED HETEROARYL-DERIVATIVES AND USE THEREOF AS ANTI-TUMOR AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-10 WO disclosed
US-3989744-A STIMULATES SMOOTH MUSCLES, PROSTAGLANDINS MILES LABORATORIES, INC. (US) 1976-11-02 US disclosed